Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dirceu Barbano reappointed head of Brazil's Anvisa

This article was originally published in SRA

Executive Summary

Dirceu Barbano has been reappointed director of Brazilian healthcare products regulatory agency Anvisa for a second three-year term. The priorities for Anvisa during Mr Barbano’s tenure will be to make the agency "more efficient without compromising on the rigour that characterises its decision-making". This will be achieved by "improving the regulatory framework [and through] closer dialogue with society", Mr Barbano told the Senate's Social Affairs Commission (CAS), which gave final approval to the appointment. Mr Barbano, a pharmacist, joined Anvisa in October 2008 and has been serving as the agency's director-president since January 2011.

You may also be interested in...

Majority Of Spanish OTC Firms Investing Heavily In Digital

A recent ANEFP survey shows that the majority of Spanish OTC firms consider their digital strategies to be "very advanced."

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

Novartis Targets Ten Indications For Cosentyx

The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts